Urinary Bladder Neoplasms
📧 Sign up to get email alerts when something new happens for Urinary Bladder Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder [Phase 3]
Phase 3 trial comparing TAR-200 plus cetrelimab versus concurrent chemoradiotherapy in muscle-invasive bladder cancer is active but not recr…
-
CLINICAL_TRIALS trial_result · 2026-04-28Clinical Trial Update: Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992) [Phase 3]
Phase 3 trial evaluating pembrolizumab with chemoradiotherapy versus chemoradiotherapy alone in muscle-invasive bladder cancer.
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder [Phase 2]
Phase 2 trial update evaluating TAR-200 in combination with cetrelimab or cetrelimab alone in muscle-invasive urothelial carcinoma of the bl…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) [Phase 1]
A Phase 1 trial of intravesical Enfortumab Vedotin for non-muscle invasive bladder cancer was terminated, with the study status updated acco…
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: A Study Comparing the Efficacy and Safety of Nivolumab in Combination With Bacillus Calmette-Guerin (BCG) Versus BCG Alone in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) [Phase 3]
Phase 3 trial evaluating nivolumab in combination with Bacillus Calmette-Guérin (BCG) versus BCG alone in high-risk non-muscle invasive blad…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid Tumours [Phase 1, Phase 2]
A first-in-human Phase 1/2 study evaluating the safety and tolerability of AZD8853 in selected advanced/metastatic solid tumors (urinary bla…
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: AGEN1884 Plus AGEN2034 Combined With Cisplatin-Gemcitabine for Muscle-Invasive Bladder Cancer [Phase 2]
Phase 2 trial evaluating AGEN1884 plus AGEN2034 with cisplatin-gemcitabine for muscle-invasive bladder cancer was terminated, with results p…
-
CLINICAL_TRIALS trial_result · 2023-06-01Clinical Trial Update: A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder [Phase 2]
Phase 2 trial evaluating nivolumab alone or with an experimental agent (BMS-986205) with or without BCG in BCG-unresponsive bladder cancer; …
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: The Bladder Instillation Comparison Study [Phase 3]
Phase 3 clinical trial update for bladder instillation therapy in urinary bladder neoplasms; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-12-28Clinical Trial Update: Comprehensive Bladder Preservation Therapy on Patients With Muscle Invasive Bladder Cancer [Phase 2]
Phase 2 clinical trial update on bladder-preservation therapy for muscle-invasive bladder cancer.
-
CLINICAL_TRIALS trial_result · 2021-10-06Clinical Trial Update: Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients [Phase 4]
Phase 4 clinical trial update exploring low-dose neuroleptanalgesia for postoperative delirium in elderly patients; current status is unknow…
-
CLINICAL_TRIALS trial_result · 2021-06-11Clinical Trial Update: Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01) [Phase 1, Phase 2]
Clinical trial update on tislelizumab in combination with BCG for high-risk non-muscle invasive bladder cancer (HR-NMIBC) across Phase 1 and…
-
CLINICAL_TRIALS trial_result · 2021-06-09Clinical Trial Update: LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer [Phase 2]
Phase 2 trial of crizotinib in patients with c-MET or RON-positive metastatic urothelial cancer has been terminated; results were posted.
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer [Phase 1, Phase 2]
Phase 1/2 study of sacituzumab govitecan-hziy (IMMU-132) in adults with epithelial cancers; trial completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-06Clinical Trial Update: Cabozantinib for Advanced Urothelial Cancer [Phase 2]
Phase 2 clinical trial of cabozantinib in advanced urothelial cancer has completed and results were posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-05-22Clinical Trial Update: Imaging Study for FdCyd and THU Cancer Treatment [EARLY_Phase 1]
Early-phase imaging study for FdCyd and THU in cancer was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-27Clinical Trial Update: A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU) [Phase 2]
Phase II multi-histology trial evaluating FdCyd with THU in various cancers completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-04-08Clinical Trial Update: Peri-operative Aspirin Continuation Versus Discontinuation [Phase 4]
Phase 4 trial update comparing peri-operative continuation versus discontinuation of aspirin; study terminated.
-
CLINICAL_TRIALS trial_result · 2019-01-09Clinical Trial Update: Safety and Efficacy Study of MAGE-A3 + AS-15 in Patients With Muscle-invasive Bladder Cancer After Cystectomy [Phase 2]
Phase 2 safety and efficacy study of MAGE-A3 + AS-15 in muscle-invasive bladder cancer post-cystectomy was terminated; results posted in 201…
-
CLINICAL_TRIALS trial_result · 2018-10-10Clinical Trial Update: Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Bladder Cancer [Phase 2]
Phase 2 trial of paclitaxel plus gemcitabine and cisplatin in urinary bladder neoplasms was terminated with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: Cystoscopic Imaging Collection and Enhancement pROject
A completed clinical trial investigating cystoscopic imaging collection and enhancement techniques for urinary bladder neoplasms.
-
CLINICAL_TRIALS trial_result · 2014-11-26Clinical Trial Update: Gemcitabine, Cisplatin, Plus Lenalidomide as First-line Therapy for Patients With Metastatic Urothelial Carcinoma [Phase 1, Phase 2]
A combined phase 1/2 trial evaluating gemcitabine, cisplatin, and lenalidomide as first-line therapy for metastatic urothelial carcinoma (ur…
-
CLINICAL_TRIALS trial_result · 2013-08-22Clinical Trial Update: Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy Treatment [Phase 2]
Phase 2 trial evaluating tamoxifen for progressive transitional cell carcinoma of the bladder after prior chemotherapy has completed, with r…